Dolby Laboratories (DLB) Receivables (2009 - 2026)

Dolby Laboratories (DLB) has reported Receivables for 18 consecutive years, with $622.2 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Receivables fell 4.45% year-over-year to $622.2 million; the trailing twelve-month figure through Jun 2026 stood at $622.2 million (down 4.45% YoY), and the FY2025 full-year result was $700.0 million, down 1.46% from the prior year.
• Receivables eased to $622.2 million in Q2 2026 per DLB's latest filing, from $813.2 million in the prior quarter.
• Across five years, Receivables topped out at $813.2 million in Q1 2026 and bottomed at $532.9 million in Q3 2022.
• Historically, Receivables has averaged $662.3 million across 5 years, with a median of $651.2 million in 2023.
• The sharpest annual moves came in 2022 and 2026: Receivables slipped 7.17% in 2022, then rose 16.3% in 2026.
• Over 5 years, Receivables stood at $628.7 million in 2022, then gained by 3.58% to $651.2 million in 2023, then increased by 13.82% to $741.2 million in 2024, then grew by 2.21% to $757.6 million in 2025, then slipped by 17.87% to $622.2 million in 2026.
• According to Business Quant data, Receivables over the past three periods registered $622.2 million, $813.2 million, and $757.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.